November 21, 2009 Issue 11   VOLUME 1 ISSUE 11  
Front Page
CONTENTS
View From the Top
Critical Biodefense Event Set for June 22...Still time to Participate
Mentoring Program Offers Business Advice to Israeli Companies
Truth or Lie: It’s not what you say but how you say it

VITAL
Virginia Israel Tech Alliance

VITAL Co-Directors:

Joe Meredith, Ph.D.
1-540-961-3600 ext. 2013
meredith@vitalva.com

Ralph Robbins
1-703-481-7494
robbins@vitalva.com

VITAL

SUBSCRIBE

Enter your email address in the box below to receive an email each time we post a new issue of our newsletter:


Add Remove
Send as HTML
 

VIAB’s Mission

-Promote Partnerships and Opportunities Between Companies in Virginia and Israel

-Help Maximize the Nearly 40 Incentives for Israeli Companies to do Business in Virginia

-Facilitate High-Level Connections Throughout Virginia and the Washington, D.C. Area

-Help Ensure an Israeli Company’s Success Once it is Established in Virginia

-Act as a Critical Interface for Israeli Companies with State and Local Officials

Critical Biodefense Event Set for June 22...Still time to Participate
Israeli Companies Invited to Participate in Virginia Event
http://www.viab.org/GMU/gmu.htm

Ken Alibek, MD, PhD, the world expert on Bioterrorism and the Executive Director of George Mason University’s “Center for Biodefense” announced today that a Special International Event, “Accelerating Solutions to Bioterrorism”, will take place in Virginia on June 22, the day before Bio2003 kicks off in Washington DC.  An elite group of international companies will participate in this exclusive gathering of leaders. 
“This special event could create corporate business opportunities on a global scale.  Since Israeli companies are among the world leaders in Biodefense, I will be delighted to see a large turnout of Israeli companies.”
Dr. Ken Alibek
According to Dr. Alibek, this will be a unique opportunity for Israeli companies to meet other international and US companies in their same arena.   The event concentrates on “biological weapons in the areas of detection, prophylaxis, and treatment.  This may include companies that are capable of manufacturing protective products, or for developing drug treatment for infectious diseases.   Alibek adds: “Both the US and Israel have exceptional capabilities to approach the unsolved terrorism threats.  We must collaborate in order to accelerate the solutions.  That’s what this event is all about.”

The special event will be a closed event limited to 100 of the elite in the field.  Companies must submit an application, which will be reviewed by a committee at the National Center for Biodefense.  There is no fee to participate in this special event and transportation will be provided from Washington, DC. 


For more information and Registration Application
  http://www.viab.org/GMU/gmu.htm
 


[PRINTER FRIENDLY VERSION]
Letters to the Editor

There are no letters for this article. To post your own letter, click Post Letter.

[POST LETTER]
Published by Virginia-Israel Advisory Board
Copyright © 2003 Virginia Israel Advisory Board, Office of the Governor. All rights reserved.
You have received this information because you either requested it or we believe it might be of interest to you. If you received this newsletter by mistake and do not want to receive it in the future, please type your email address in the "Subscribe/Unsubscribe" box above and indicate "Remove." You will immediately be removed from future emails.
TELL A FRIEND
Created with eNewsBuilder